BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24344258)

  • 61. Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
    Saha A; Murakami M; Kumar P; Bajaj B; Sims K; Robertson ES
    J Virol; 2009 May; 83(9):4652-69. PubMed ID: 19244339
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2.
    Bazot Q; Paschos K; Skalska L; Kalchschmidt JS; Parker GA; Allday MJ
    PLoS Pathog; 2015 Jul; 11(7):e1005031. PubMed ID: 26153983
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Roles of RUNX in B Cell Immortalisation.
    West MJ; Farrell PJ
    Adv Exp Med Biol; 2017; 962():283-298. PubMed ID: 28299664
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quality of TCR signaling determined by differential affinities of enhancers for the composite BATF-IRF4 transcription factor complex.
    Iwata A; Durai V; Tussiwand R; Briseño CG; Wu X; Grajales-Reyes GE; Egawa T; Murphy TL; Murphy KM
    Nat Immunol; 2017 May; 18(5):563-572. PubMed ID: 28346410
    [TBL] [Abstract][Full Text] [Related]  

  • 65. EBNA3C can modulate the activities of the transcription factor Necdin in association with metastasis suppressor protein Nm23-H1.
    Kaul R; Murakami M; Lan K; Choudhuri T; Robertson ES
    J Virol; 2009 May; 83(10):4871-83. PubMed ID: 19116252
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity.
    Knight JS; Robertson ES
    J Virol; 2004 Feb; 78(4):1981-91. PubMed ID: 14747563
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells.
    Kalchschmidt JS; Bashford-Rogers R; Paschos K; Gillman AC; Styles CT; Kellam P; Allday MJ
    J Exp Med; 2016 May; 213(6):921-8. PubMed ID: 27217538
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Roles of BATF/JUN/IRF4 complex in tacrolimus mediated immunosuppression on Tfh cells in acute rejection after liver transplantation.
    Tang T; Xu T; Liu X; Yang T; Zhang L; Yang Z
    J Cell Physiol; 2021 Mar; 236(3):1776-1786. PubMed ID: 32749698
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
    Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
    Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor.
    Sahu SK; Mohanty S; Kumar A; Kundu CN; Verma SC; Choudhuri T
    Virology; 2014 Jan; 448():333-43. PubMed ID: 24314664
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.
    Hsieh JJ; Hayward SD
    Science; 1995 Apr; 268(5210):560-3. PubMed ID: 7725102
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.
    Paschos K; Smith P; Anderton E; Middeldorp JM; White RE; Allday MJ
    PLoS Pathog; 2009 Jun; 5(6):e1000492. PubMed ID: 19557159
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth.
    Calderwood MA; Lee S; Holthaus AM; Blacklow SC; Kieff E; Johannsen E
    Virology; 2011 May; 414(1):19-25. PubMed ID: 21440926
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa.
    Bourillot PY; Waltzer L; Sergeant A; Manet E
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():363-70. PubMed ID: 9472621
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.
    McClellan MJ; Wood CD; Ojeniyi O; Cooper TJ; Kanhere A; Arvey A; Webb HM; Palermo RD; Harth-Hertle ML; Kempkes B; Jenner RG; West MJ
    PLoS Pathog; 2013 Sep; 9(9):e1003636. PubMed ID: 24068937
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
    Schlager S; Speck SH; Woisetschläger M
    J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
    [TBL] [Abstract][Full Text] [Related]  

  • 77. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
    Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
    J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
    [TBL] [Abstract][Full Text] [Related]  

  • 78. EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells.
    Glaser LV; Rieger S; Thumann S; Beer S; Kuklik-Roos C; Martin DE; Maier KC; Harth-Hertle ML; Grüning B; Backofen R; Krebs S; Blum H; Zimmer R; Erhard F; Kempkes B
    PLoS Pathog; 2017 Oct; 13(10):e1006664. PubMed ID: 28968461
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
    Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
    Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.
    Knight JS; Sharma N; Robertson ES
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18562-6. PubMed ID: 16352731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.